Status:

UNKNOWN

Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases

Lead Sponsor:

Good Samaritan Hospital Medical Center, New York

Conditions:

Metastatic Brain Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In this study the patient will receive either whole brain radiation therapy given by intensity modulated radiation therapy (IMRT) or standard conventional radiation. In IMRT therapy radiation dose to ...

Detailed Description

SCHEMA For Patients with MRI Evidence of Brain Metastasis within 1 Month Prior to Registration Prior to Treatment Start Confirmation of patient's insurance coverage prior to receiving study-related p...

Eligibility Criteria

Inclusion

  • ELIGIBILITY CHECKLIST
  • Evidence of at least one brain metastasis on a gadolinium contrast-enhanced MRI
  • Pathologic/histological/cytologic proof of a diagnosis of a non-hematopoietic malignancy within 5 years of study entry.
  • Patient ≥18 years of age?
  • Fall into RTOG Recursive Partition Analysis (RPA) class I or II.
  • Karnofsky Performance Score ≥70. (See Appendix III)
  • Biopsy done at least 1 week prior to registration. (This requirement does not apply to stereotactic biopsies.)

Exclusion

  • Contraindication to MR imaging such as implanted metal devices or foreign bodies, severe claustrophobia.
  • Creatinine level \> 1.4 mg/dl drawn ≤30 days prior to study entry.
  • Severe, active co-morbitities.
  • Unstable angina, and/or congestive heart failure requiring hospitalization within the last 6 months.
  • Transmural myocardial infarction within the last 6 months
  • Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
  • Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
  • Uncontrolled, clinically significant cardiac arrhythmias
  • Pregnancy

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2017

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01890278

Start Date

June 1 2013

End Date

March 1 2017

Last Update

July 1 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Good Samaritan Hospital Medical Center

West Islip, New York, United States, 11795